+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major

A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major

Southeast Asian Journal of Tropical Medicine and Public Health 24(Suppl. 1): 92-95

Increased frequency of thromboembolic events has been recently observed in patients with thalassemia major (TM), causing hypoxemia and cor pulmonale. Autopsy findings demonstrated "old" and recent pulmonary and renal infarcts as well as premature atherosclerosis. Studies to determine hypercoagulability showed: impaired platelet aggregation, increased circulating platelet aggregates, shortened platelet survival, enhanced excretion of urinary metabolites of thromboxane A2 (TXA2) and prostacyclin and decreased plasma levels of Protein C, Protein S or anti-thrombin III. Erythrocytes from TM patients enhanced thrombin formation in a "prothrombinase" assay (using a chromogenic substrate). Chronic anti-thrombotic therapy may be indicated in thalassemic patients to prevent the cardiac and pulmonary complications.

(PDF emailed within 1 workday: $29.90)

Accession: 045042361

Download citation: RISBibTeXText

PMID: 7886616

Related references

Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. American Journal of Hematology 81(9): 670-675, 2006

Study of platelet activation, hypercoagulable state, and the association with pulmonary hypertension in children with β-thalassemia. Hematology/Oncology and Stem Cell Therapy 11(2): 65-74, 2017

The hypercoagulable state in beta-thalassemia major Increased red blood cell aggregation occurs under controlled flow. Blood 82(10 SUPPL 1): 469A, 1993

Hypercoagulable state and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with beta-thalassemia major in Kuwait. Acta Haematologica 123(1): 37-42, 2010

Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. American Journal of Hematology 44(1): 63-65, 1993

In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood 77(8): 1749-1753, 1991

A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. British Journal of Haematology 107(4): 739-746, 1999

Hypercoagulable state as demonstrated by thromboelastometry in hemoglobin E/beta-thalassemia patients: Association with clinical severity and splenectomy status. Thrombosis Research 140: 125-131, 2016

Effect of Coagulation and Platelet Activation on Tumor-Associated Hypercoagulable State in Lymphoma-Bearing Mice. Zhongguo Shi Yan Xue Ye Xue Za Zhi 26(2): 427-431, 2018

Platelet function in beta thalassemia major. Journal of Clinical Pathology 32(5): 429-433, 1979

The prevalence of hypercoagulable state among patients with chronic major vessel thromboembolic pulmonary hypertension. Blood 90(10 SUPPL 1 PART 2): 121B, Nov 15, 1997

Effective components of Panax quinquefolius and Corydalis tuber protect the myocardium by inhibiting platelet activation and improving the hypercoagulable state. Experimental and Therapeutic Medicine 9(4): 1477-1481, 2015

Long-term strenuous exercise induces a hypercoagulable state through contact activation. Thrombosis and Haemostasis 111(6): 1197-1199, 2015

Platelet aggregation and activation in thalassemia major patients in Indonesia. Clinical and Applied Thrombosis/Hemostasis 14(3): 346-351, 2007

Thalassemia and the hypercoagulable state. Thrombosis Research 132(6): 637-641, 2014